Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Annals of Surgical Oncology|May 8, 2013
Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinomaSun Hong Yoo, Jong Young Choi, Jeong Won Jang, et al.Scientific Reports|March 3, 2019
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolizationHae Lim Lee, Jeong Won Jang, Sung Won Lee, et al.Gut and Liver|February 21, 2013
DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot StudyDo Seon Song, Jong Young Choi, Sun Hong Yoo, et al.European Journal of Gastroenterology & Hepatology|February 2, 2023
Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infectionJungnam Lee, Jong-In Chang, Young-Joo Jin, et al.Journal of Gastroenterology and Hepatology|September 16, 2011
Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastasesSeung Min Jung, Jeong Won Jang, Chan Ran You, et al.The Korean Journal of Internal Medicine|September 2, 2009
Significance of inflammatory markers in diabetic patients with stable coronary artery diseaseHyo-Jin Lee, Sung-Ho Her, Yun-Sun Im, et al.World Journal of Gastroenterology|November 28, 2012
Durability of viral response after off-treatment in HBeAg positive chronic hepatitis BMyeong Jun Song, Do Seon Song, Hee Yeon Kim, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Association of Prophylactic Anti-Hepatitis B Virus Therapy With Improved Long-term Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial TherapyJeong Won Jang, Sun Hong Yoo, Hee Chul Nam, et al.Plos One|December 8, 2021
Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathwaySung Won Lee, Sung Min Kim, Wonhee Hur, et al.Journal of Hepatology|April 10, 2022
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearanceHyun Yang, Si Hyun Bae, Heechul Nam, et al.Pageof 4